Tag: lexaria bioscience corp
November 29, 2019
Lexaria Announces 2nd Tranche Closing of Non-Brokered Private Placement
Lexaria Bioscience Corp. announces it has closed the second tranche of its previously announced private placement of units as at... November 21, 2019
Lexaria’s Technology Now Works in Less Than 10 Minutes
Lexaria Bioscience Corp. announces it has developed additional enhancements for its industry-leading DehydraTECHTM platform. November 14, 2019
Lexaria Announces Closing of Non-Brokered Private Placement
Lexaria Bioscience Corp. announces it has closed the first tranche of its previously announced private placement of units as at... November 5, 2019
Lexaria Bioscience Appoints Gregg Smith as Senior Advisor
Lexaria Bioscience Corp. is very pleased to announce the appointment of Gregg Smith, Founder of Evolution VC Partners, as Senior... October 30, 2019
Lexaria Equity Financing and Corporate Strategy Update
Lexaria Bioscience Corp. announces it is arranging a non-brokered private placement for gross proceeds of approximately US$1 million. October 24, 2019
Lexaria Applauds FDA Decision on Reduced Risk Tobacco Format
Lexaria Bioscience Corp. is very pleased to report that the Food and Drug Administration has authorized the marketing of oral nicotine...
October 22, 2019